Vioguard

Vioguard is a biotechnology and healthcare startup based in the United States, founded in 2008. The company's slogan "More than clean. Sanitized." reflects its commitment to developing innovative products aimed at combating the spread of harmful bacteria and viruses. Vioguard utilizes a patented ultraviolet light (UV-C) dosimeter in its products, ensuring the precise amount of germicidal power for each use. UV-C is a well-known disinfectant capable of inactivating harmful microorganisms within seconds, offering an effective solution to the growing concerns over infectious diseases. The company recently secured a $5.00M Series A investment on 25th January 2017, with Imagen Capital Partners participating as the lead investor, reflecting the confidence of investors in Vioguard's technology and potential for addressing critical healthcare challenges. With its focus on leveraging UV-C technology for sanitization and disinfection, Vioguard is well-positioned to make a meaningful impact in the context of emerging health crises and the broader healthcare industry.